N4 Pharma Plc (LON:N4P – Get Free Report)’s share price was up 9.1% during mid-day trading on Thursday . The company traded as high as GBX 0.60 ($0.01) and last traded at GBX 0.60 ($0.01). Approximately 740,838 shares changed hands during trading, a decline of 28% from the average daily volume of 1,027,283 shares. The stock had previously closed at GBX 0.55 ($0.01).
N4 Pharma Trading Up 4.3 %
The company has a market cap of £2.37 million, a PE ratio of -55.00 and a beta of -0.37. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62. The stock’s 50 day moving average is GBX 0.56 and its 200-day moving average is GBX 0.60.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than N4 Pharma
- Profitably Trade Stocks at 52-Week Highs
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- Health Care Stocks Explained: Why You Might Want to Invest
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Investing In Preferred Stock vs. Common Stock
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
